Table 3:
Summary of recipient and donor covariates for deceased-donor kidney recipients with ≥ 3-year follow-up. This cohort consists of recipients who received transplant between 2007/01/01–2012/09/02.
| Covariate | N=53242 | |
|---|---|---|
| Donor | Donor Age (mean±SD) | 39.30±15.79 |
| Donor Race Caucasian Asian Black Other |
82.77% 2.32% 14.04% 0.88% |
|
| Donor Blood Type A AB B O |
36.71% 3.66% 12.15% 47.49% |
|
| Donor BMI (mean±SD) | 27.46±6.69 | |
| Donor BUN in mg/dL (mean±SD) Missing |
16.42±11.04 0.54% |
|
| Donor Cause of Death Anoxia Cerebrovascular/Stroke Head Trauma Central Nervous System Tumor Other |
23.89% 35.79% 37.12% 0.50% 2.70% |
|
| Donor Clinical Infection of the Lung Positive |
40.58% |
|
| Donor Creatinine (mean±SD) Missing |
1.14±1.02 3.12% |
|
| Donor Diuretics Positive Missing |
58.15% 0.17% |
|
| Donor Drug-Treated Systematic Hypertension Positive Missing |
20.43% 0.20% |
|
| Donor eGFR Missing |
91.68±39.35 3.12% |
|
| Donor Hematocrit (mean±SD) Missing |
31.29±5.86 0.11% |
|
| Donor Hepatitis C Virus Result Positive Unknown/Missing |
2.52% 0.03% |
|
| Donor History of Diabetes Positive Unknown |
7.46% 0.48% |
|
| Donor INR (mean±SD) Missing |
1.39±1.36 1.63% |
|
| Donor KDRI (mean±SD) Missing |
1.26±0.40 3.96% |
|
| Kidney Transplanted Locally | 75.32% | |
| Kidney Pumped | 23.57% | |
| Donor Tattoos Yes Missing |
30.19% 0.40% |
|
| Donor- Recipient |
HLA B Mismatches 0 1 2 |
12.98% 23.71% 63.30% |
| HLA DR Mismatches 0 1 2 |
21.91% 44.16% 33.93% |
|
| Recipient | Recipient Age at Transplant (mean±SD) | 52.74±13.12 |
| Latino | 14.71% | |
| Recipient Race Caucasian Asian Black Other |
59.19% 6.00% 33.09% 1.72% |
|
| BMI (mean±SD) Missing |
28.19±5.57 3.50% |
|
| Diabetes Type 1 Type 2 Other |
4.55% 26.00% 5.16% |
|
| Education Grade School/None High School Technical/Some College College Unknown/Missing |
6.62% 41.50% 21.91% 19.10% 10.87% |
|
| Gender Male Female |
60.57% 39.43% |
|
| HBV Core Antibody Positive Unknown/Missing |
8.43% 14.83% |
|
| HCV Serostatus Positive Unknown/Missing |
5.69% 4.21% |
|
| Had Previous Malignancy Positive Unknown/Missing |
5.17% 2.58% |
|
| Had Previous Transplant | 14.22% | |
| Kidney Cold Ischemia Time in Hours (mean±SD) Missing |
17.84±9.46 2.64% |
|
| Kidney Primary Diagnosis at Transplant Congenital, Rare Familial, & Metabolic Disorders Diabetes Glomerular Diseases Hypertensive Nephrosclerosis Unknown/Other |
1.78% 27.47% 22.84% 28.32% 19.60% |
|
| Most Recent CPRA (mean±SD) Missing |
15.35±28.78 6.19% |
|
| Peripheral Vascular Disease Positive Unknown |
4.38% 3.51% |
|
| Primary Payment Public Private/Other/Unknown |
73.75% 26.25% |
|
| Procedure Type Left Kidney Right Kidney |
47.03% 52.97% |
|
| Total ESRD Time at Transplant in Days (mean±SD) | 1549.52±1124.83 | |
| Total Serum Albumin at Listing (mean±SD) Missing |
3.91±0.58 15.99% |
|
| Karnofsky Score at Transplant 10–30 40–50 60–70 80–90 100 Unknown |
0.16% 3.31% 23.47% 54.63% 14.77% 3.66% |
|
| Death within 3 years | 9.16% (4879) |
BMI: body mass index
BUN: blood urea nitrogen
CPRA: calculated panel reactive antibodies
eGFR: estimated glomerular filtration rate
ESRD: end-stage renal disese
HLA: human leukocyte antigens
HBV: hepatitis B virus
HCV: hepatitis C virus
INR: international normalized ratio
SD: standard deviation